Funds holding Arcutis Biotherapeutics Inc
ISIN US03969K1088 · United States
- Fund holders
- 234
- Of which ETFs
- 47 187 other funds
- Value held
- 759.7M $ 259.3K € · 9.3M SEK
- Share of capital
- 25.3 % of 125.7M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 2,402 | 55.8K $ | 0.07 % | 0.00 % | as of Apr 30, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 2,006 | 47.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Longboard Fund NORTHERN LIGHTS FUND TRUST II | 1,959 | 52.8K $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Strategic Allocation: Aggressive Fund American Century Strategic Asset Allocations Inc | 1,904 | 44.2K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,894 | 44.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 1,671 | 45.1K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,658 | 39.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Strategic Allocation: Moderate Fund American Century Strategic Asset Allocations Inc | 1,434 | 33.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| American Century Small Cap Growth Insights ETF American Century ETF Trust | 1,388 | 37.4K $ | 0.42 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 1,321 | 35.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,240 | 28.8K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 958 | 22.2K $ | 0.14 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SIMT Multi-Asset Inflation Managed Fund SEI INSTITUTIONAL MANAGED TRUST | 892 | 21K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Variable Insurance Trust Small Cap Equity Insights Fund Goldman Sachs Variable Insurance Trust | 715 | 16.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 647 | 15.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Franklin Tactical Opportunities Portfolio SUNAMERICA SERIES TRUST | 624 | 14.5K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 598 | 13.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 546 | 12.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Strategic Allocation: Conservative Fund American Century Strategic Asset Allocations Inc | 474 | 11K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 400 | 9.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 368 | 8.7K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 309 | 8.3K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 288 | 6.7K $ | 0.09 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 278 | 6.5K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 251 | 5.9K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 201 | 4.7K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 150 | 3.5K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 113 | 3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 112 | 2.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 106 | 2.5K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 37 | 997.9 $ | 0.09 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 29 | 683.2 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 148.3K € | 1.11 % | as of Dec 31, 2025 ↗ | ||
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 110.9K € | 3.02 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 3.02 % | as of Dec 31, 2025 ↗ |
| Lazard Retirement US Small Cap Equity Select Portfolio LAZARD RETIREMENT SERIES INC | 1.47 % | as of Mar 31, 2026 ↗ |
| Lazard US Small Cap Equity Select Portfolio LAZARD FUNDS INC | 1.46 % | as of Mar 31, 2026 ↗ |
| Baron Health Care Fund BARON SELECT FUNDS | 1.43 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Small Company Fund Prudential Jennison Small Co Fund, Inc. | 1.29 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 1.28 % | as of Apr 30, 2026 ↗ |
| PGIM Jennison Small-Cap Core Equity Fund Prudential Investment Portfolios 2 | 1.15 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 1.13 % | as of Apr 30, 2026 ↗ |
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 1.11 % | as of Dec 31, 2025 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1.09 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 231 | +6 | 31,738,807 | +0.4 % |
| 2026Q1 | 225 | +40 | 31,599,040 | +6.5 % |
| 2025Q4 | 185 | +7 | 29,667,596 | -3.2 % |
| 2025Q3 | 178 | -3 | 30,654,308 | -4.0 % |
| 2025Q2 | 181 | +21 | 31,920,044 | +0.3 % |
| 2025Q1 | 160 | +7 | 31,812,634 | -2.2 % |
| 2024Q4 | 153 | +6 | 32,538,746 | +13.5 % |
| 2024Q3 | 147 | +12 | 28,679,801 | -6.5 % |
| 2024Q2 | 135 | +8 | 30,663,928 | +39.8 % |
| 2024Q1 | 127 | -11 | 21,933,767 | +3.5 % |
| 2023Q4 | 138 | 21,191,574 |
Institutional managers
259 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 12,327,000 | 290.4M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 9,874,511 | 232.6M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 9,200,411 | 216.8M $ | as of Mar 31, 2026 |
| Rubric Capital Management LP | 8,271,577 | 194.9M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 6,296,197 | 148.3M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 5,666,940 | 133.5M $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 4,980,770 | 117.3M $ | as of Mar 31, 2026 |
| GILDER GAGNON HOWE & CO LLC | 4,304,010 | 101.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 4,218,931 | 99.4M $ | as of Mar 31, 2026 |
| UBS Group AG | 3,329,224 | 78.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,045,306 | 71.8M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 2,496,222 | 58.8M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 2,431,778 | 57.3M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,297,943 | 54.1M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 2,226,029 | 52.4M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,221,289 | 52.3M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 1,854,566 | 43.7M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,603,013 | 37.8M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,463,228 | 34.5M $ | as of Mar 31, 2026 |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,365,941 | 32.2M $ | as of Mar 31, 2026 |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,355,892 | 31.9M $ | as of Mar 31, 2026 |
| Ensign Peak Advisors, Inc | 1,244,387 | 29.3M $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 1,103,490 | 26M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 1,086,651 | 25.6M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 1,077,267 | 25.4M $ | as of Mar 31, 2026 |
Declared shareholders of Arcutis Biotherapeutics Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| STATE STREET CORPORATION | 5.10 % | 6,296,197 | as of Mar 31, 2026 · SCHEDULE 13G |
| PRUDENTIAL FINANCIAL INC | 4.30 % | 5,302,713 | as of Mar 31, 2026 · SCHEDULE 13G |
| Jennison Associates LLC | 4.00 % | 4,980,770 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Arcutis Biotherapeutics Inc". https://titelia.com/en/stocks/arcutis-biotherapeutics-inc-US03969K1088